成人重型和输血依赖的非重型再生障碍性贫血中西医结合诊疗专家共识

2021-03-28 2015中医药行业科研专项再生障碍性贫血项目专家组 中华中医药杂志

通过组织全国中医血液病重点学科与重点专科建设单位部分专家讨论,就成人重型和输血依赖的非重型再生障碍性贫血的中西医结合诊疗方案达成一致意见并形成了较为完善的诊治规范体系。

中文标题:

成人重型和输血依赖的非重型再生障碍性贫血中西医结合诊疗专家共识

发布日期:

2021-03-28

简要介绍:

通过组织全国中医血液病重点学科与重点专科建设单位部分专家讨论,就成人重型和输血依赖的非重型再生障碍性贫血的中西医结合诊疗方案达成一致意见并形成了较为完善的诊治规范体系。在再生障碍性贫血(简称“再障”)诊断明确的前提下,对于成人重型再障(急髓劳病),有相合供者且条件适合者优先选择异基因骨髓移植,无相合供者首选强烈免疫抑制治疗与中医药的联合应用以截断细胞因子风暴;对于成人输血依赖的非重型再障(慢髓劳病)首选中医药与雄激素的联合应用以促进骨髓造血功能恢复。文章就再障的诊断与鉴别诊断、中医辨证论治、西医基础治疗等给予具体的诊治建议,以期为中西医结合诊疗再障提供指导和帮助。

相关资料下载:
[AttachmentFileName(sort=1, fileName=成人重型和输血依赖的非重型再生障碍性贫血中西医结合诊疗专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5f5171c00235e048, title=成人重型和输血依赖的非重型再生障碍性贫血中西医结合诊疗专家共识, enTitle=, guiderFrom=中华中医药杂志, authorId=0, author=, summary=通过组织全国中医血液病重点学科与重点专科建设单位部分专家讨论,就成人重型和输血依赖的非重型再生障碍性贫血的中西医结合诊疗方案达成一致意见并形成了较为完善的诊治规范体系。, cover=https://img.medsci.cn/2022215/1644935615692_5579292.jpg, journalId=0, articlesId=null, associationId=2427, associationName=2015中医药行业科研专项再生障碍性贫血项目专家组, associationIntro=2015中医药行业科研专项再生障碍性贫血项目专家组, copyright=0, guiderPublishedTime=Sun Mar 28 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">通过组织全国中医血液病重点学科与重点专科建设单位部分专家讨论,就成人重型和输血依赖的非</span><span style="color: #373737;">重型再生障碍性贫血的中西医结合诊疗方案达成一致意见并形成了较为完善的诊治规范体系。在再生障碍性贫血</span><span style="color: #373737;">(简称&ldquo;再障&rdquo;)诊断明确的前提下,对于成人重型再障(急髓劳病),有相合供者且条件适合者优先选择异基</span><span style="color: #373737;">因骨髓移植,无相合供者首选强烈免疫抑制治疗与中医药的联合应用以截断细胞因子风暴;对于成人输血依赖的</span><span style="color: #373737;">非重型再障(慢髓劳病)首选中医药与雄激素的联合应用以促进骨髓造血功能恢复。文章就再障的诊断与鉴别诊</span><span style="color: #373737;">断、中医辨证论治、西医基础治疗等给予具体的诊治建议,以期为中西医结合诊疗再障提供指导和帮助。</span></p>, tagList=[TagDto(tagId=117037, tagName=髓系疾病), TagDto(tagId=123041, tagName=非重型再生障碍性贫血)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3436, appHits=46, showAppHits=0, pcHits=281, showPcHits=3390, likes=0, shares=4, comments=2, approvalStatus=1, publishedTime=Wed Feb 16 15:31:00 CST 2022, publishedTimeString=2021-03-28, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Feb 15 22:37:29 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 20:03:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=成人重型和输血依赖的非重型再生障碍性贫血中西医结合诊疗专家共识.pdf)])
成人重型和输血依赖的非重型再生障碍性贫血中西医结合诊疗专家共识.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220717, encodeId=3ba21220e1798, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d416160714, createdName=ms8000000185867059, createdTime=Wed May 18 19:22:58 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220716, encodeId=25451220e161d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d416160714, createdName=ms8000000185867059, createdTime=Wed May 18 19:22:39 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-05-18 ms8000000185867059

    学习一下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220717, encodeId=3ba21220e1798, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d416160714, createdName=ms8000000185867059, createdTime=Wed May 18 19:22:58 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220716, encodeId=25451220e161d, content=👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2d416160714, createdName=ms8000000185867059, createdTime=Wed May 18 19:22:39 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-05-18 ms8000000185867059

    👍

    0